View all trials
Showing 9 results

The table can be sorted by “Study title” or “Protocol ID” sorted alphabetically in either Ascending (default) or Descending (on second click) order.
The default sorting is by “Study title” in alphabetical ascending order.

Study titleProtocol IDDisease type(s)Location(s)Eligibility criteriaStatus
A Phase 2 Randomised Study of Irinotecan/Temozolomide/Dinutuximab with or without Eflornithine (DFMO) (IND# TBD) in Children with Relapsed, Refractory or Progressive Neuroblastoma ANBL1821
Solid tumours
Neuroblastoma
Queensland Children's HospitalBrisbane
External site Open
A Phase I Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects with Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma EZH102
Solid tumours
Children's Hospital at WestmeadSydney
Queensland Children's HospitalBrisbane
Royal Children's Hospital Melbourne
Sydney Children's Hospital
Open
A Phase II Study of Panobinostat in Paediatric, Adolescent and Young Adult Patients with Solid Tumours Including Osteosarcoma, Malignant Rhabdoid Tumour/Atypical Teratoid Rhabdoid Tumours and Neuroblastoma NORTH / ACCT008
Brain and Spinal Tumours
ATRT
Solid tumours
Neuroblastoma
Solid tumours
Osteosarcoma
Christchurch HospitalChristchurch, New Zealand
John Hunter Children's HospitalNewcastle
Monash Children's HospitalMelbourne
Queensland Children's HospitalBrisbane
Royal Children's Hospital Melbourne
Royal Hobart HospitalHobart
Starship Children's HospitalAuckland, NZ
Sydney Children's Hospital
External site Open
European Low and Intermediate Risk Neuroblastoma - A SIOPEN Study LINES
Solid tumours
Neuroblastoma
Monash Children's HospitalMelbourne
Sydney Children's Hospital
External site Open
International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma rEECur; RG_13-277
Solid tumours
Ewings sarcoma
Christchurch HospitalChristchurch, New Zealand
John Hunter Children's HospitalNewcastle
Monash Children's HospitalMelbourne
Perth Children's HospitalPerth
Queensland Children's HospitalBrisbane
Starship Children's HospitalAuckland, NZ
Sydney Children's Hospital
External site Open
National Wilms Tumor Late Effects Study 4941L
Solid tumours
Renal/kidney
Perth Children's HospitalPerth
Open
Neuroblastoma Biology Studies ANBL00B1
Solid tumours
Neuroblastoma
Children's Hospital at WestmeadSydney
John Hunter Children's HospitalNewcastle
Perth Children's HospitalPerth
Queensland Children's HospitalBrisbane
Royal Children's Hospital Melbourne
Sydney Children's Hospital
Women and Children's HospitalAdelaide
Open
Open-Label, Dose-Escalation, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics & Clinical Activity of the MEK Inhibitor Trametinib in children and adolescent subjects with Cancer or Plexiform Neurofibromas & Trametinib GSK MEK
Solid tumours
Other Solid Tumour
Children's Hospital at WestmeadSydney
Open
Solid tumour and leukaemia banking Tumour Bank
Brain and Spinal Tumours
Other Brain and Spinal Tumour
Leukaemia
Other Leukaemia
Lymphoma
Other Lymphoma
Solid tumours
Other Solid Tumour
Queensland Children's HospitalBrisbane
Open